EVALUATION PLATFORMS

Evaluation Platforms for Diagnostic Materials and Assays

EXIMIO uses multiple evaluation platforms to support the assessment of diagnostic raw materials, reagent combinations and assay formulations throughout development.

ELISA, lateral flow immunoassay and Bio-Layer Interferometry provide complementary approaches for reviewing material performance, molecular interactions and practical assay behavior.

THREE EVALUATION PLATFORMS
01
ELISA

Plate-based evaluation for antigen-antibody and immunoassay performance.

02
Lateral Flow Immunoassay

Practical evaluation using colloidal gold and fluorescent conjugate systems.

03
Bio-Layer Interferometry

Real-time, label-free analysis of molecular interactions.

EVALUATION CAPABILITY

Three Platforms, Different Technical Perspectives

Different stages of diagnostic development require different evaluation approaches. These platforms can support material screening, reagent comparison, assay development and molecular interaction analysis according to project requirements.

01

ELISA Platform

Supports plate-based evaluation of immunoreactivity and relevant antigen-antibody performance during material assessment.

02

Lateral Flow Platform

Supports practical assay evaluation through colloidal gold and fluorescent conjugate-based lateral flow systems.

03

BLI Platform

Supports real-time and label-free molecular interaction analysis, including association, dissociation and comparative affinity evaluation.

PLATFORM 01

ELISA Evaluation Platform

ELISA provides a familiar plate-based approach for evaluating antigen-antibody reactions and immunoassay-related material performance.

The platform can be used during material screening and comparison where plate-based signal evaluation is appropriate for the development project.

01

Antigen-antibody reactivity evaluation

02

Candidate material comparison

03

Immunoassay-oriented screening support

EXIMIO ELISA evaluation platform
PLATFORM 02

Lateral Flow Immunoassay Platform

Lateral flow evaluation allows diagnostic materials and formulations to be reviewed directly within a rapid test format.

EXIMIO's evaluation capability includes both colloidal gold and fluorescent conjugate approaches, allowing different signal systems to be considered according to the assay.

01

Colloidal Gold Conjugates Platform

Supports lateral flow evaluation using colloidal gold-based signal generation and conjugate systems.

02

Fluorescent Conjugates Platform

Supports lateral flow evaluation using fluorescent conjugates where this signal format is suitable for the project.

EXIMIO lateral flow immunoassay evaluation platform
PLATFORM 03

Bio-Layer Interferometry

Bio-Layer Interferometry provides quantitative and dynamic information about molecular interactions through real-time, label-free analysis.

This provides another perspective for evaluating diagnostic biomaterials before or alongside downstream assay development.

EXIMIO Bio-Layer Interferometry platform
PLATFORM FEATURES
01

Label-Free Analysis

Molecular interactions can be evaluated without introducing a conventional labeling step into the interaction being measured.

02

Real-Time Interaction Monitoring

Association and dissociation behavior can be observed over time rather than relying only on a single endpoint measurement.

03

Dip-and-Read Format

Sensor-based measurement provides a practical approach for interaction analysis across relevant biomaterial samples.

BLI APPLICATIONS

Molecular Interaction Evaluation

BLI can be incorporated into suitable projects where molecular interaction information can support reagent screening, characterization or diagnostic development decisions.

01

Molecular Interaction Evaluation

Review whether a measurable interaction occurs between selected molecular partners.

02

Modified Protein Analysis

Support comparative analysis of relevant modified protein samples where interaction behavior is important.

03

Antibody Evaluation

Support antibody screening, paired antibody screening, clone comparison and antigen-antibody affinity evaluation.

04

Protein–Polypeptide Interactions

Evaluate relevant interaction behavior between proteins and polypeptide targets.

05

Protein–Virus / Bacteria Interactions

Support relevant molecular interaction studies involving proteins and viral or bacterial targets.

06

Protein–DNA / RNA Interactions

Evaluate suitable interaction systems involving proteins and nucleic-acid targets.

07

Protein–Nanoparticle Interactions

Support interaction analysis between selected protein materials and nanoparticle systems.

08

Binding Site Research

Provide molecular interaction information that may support project-specific binding studies.

CONNECTED EVALUATION

From Molecular Interaction to Practical Assay Performance

No single analytical platform answers every development question. Different evaluation methods can provide complementary information depending on the material and project stage.

01
Screen Materials

Compare relevant candidate reagents and materials.

02
Evaluate Interactions

Review molecular interaction behavior where appropriate.

03
Test Assay Performance

Evaluate selected materials within relevant assay formats.

04
Support Optimization

Use evaluation results to guide subsequent development work.

TECHNICAL EVALUATION

Need evaluation support for your diagnostic materials?

Contact EXIMIO to discuss ELISA, lateral flow, BLI or other project-specific material evaluation requirements.